Gut Wealth’s Gemma Stuart on turning science-led gut health into a scalable business This month we caught up with Gemma Stuart, founder of Equity Gap portfolio company Gut Wealth – an Edinburgh-based business developing science-backed digestive health supplements. Built from her own experience with IBS, which affects around one in 20 people in the UK,… Continue reading Gut Wealth’s Gemma Stuart on turning science-led gut health into a scalable business
Category: News
ULEMCO wins the Innovation Award for the North-West Region at the Small Business Growth Awards
Equity Gap are delighted to congratulate portfolio company, ULEMCo, on being recognised in the 2026 Small Business Growth Awards, delivered jointly by HSBC Commercial Banking and the Federation of Small Businesses. ULEMCo received the Innovation Award for the North-West region in recognition of its progress in hydrogen dual-fuel vehicle conversion, development of new hydrogen technologies,… Continue reading ULEMCO wins the Innovation Award for the North-West Region at the Small Business Growth Awards
EnteroBiotix secures £19m to Initiate Phase 2b Clinical Trial for Irritable Bowel Syndrome
Equity Gap Portfolio, EnteroBiotix, has today announced the completion of a £19 million ($25 million) financing to advance EBX-102-02, its orally delivered investigational microbiome therapeutic, into Phase 2b development for Irritable Bowel Syndrome with Constipation (IBS-C). The round was led by Thairm Bio and the Scottish National Investment Bank, with participation from new and existing… Continue reading EnteroBiotix secures £19m to Initiate Phase 2b Clinical Trial for Irritable Bowel Syndrome
Interpac receives Certificate of Grant for their US Patent
A significant milestone for Equity Gap portfolio company Interpac. We’re pleased to see Interpac secure both a US patent and an additional international patent from Taiwan, strengthening its global IP position and commercial potential. Interpac’s patented cold corrugation technology helps sheet converters improve efficiency, reduce costs, and gain greater control over production — demonstrating the… Continue reading Interpac receives Certificate of Grant for their US Patent
MI:RNA shortlisted for 2026 Scottish Business of the Year Award
Equity Gap are delighted that their portfolio company, MI:RNA have been named on the innovation shortlist for the 2026 Scottish Business of the Year Awards. To be recognized alongside companies shaping the future of their industries is a meaningful moment for our team.
Vector Photonics wins at the University of Glasgow Knowledge Exchange & Innovation Awards
Equity Gap are delighted to congratulate Vector Photonics on winning the Champion Spin-out Award at the University of Glasgow Knowledge Exchange & Innovation Awards 2026. This recognition reflects not only technological innovation, but also the commitment, resilience, and ambition of the exceptional Vector team and its partners. A huge thank you to everyone at the… Continue reading Vector Photonics wins at the University of Glasgow Knowledge Exchange & Innovation Awards
SeaWarm’s Isabel DiPirro, Head of Operations & Sustainability, on market demand, commercialisation and national expansion
SeaWarm’s Isabel DiPirro, Head of Operations & Sustainability, on market demand, commercialisation and national expansion This month, we spoke to Isabel DiPirro, Head of Operations & Sustainability at Equity Gap portfolio company SeaWarm – a Scottish renewable energy spinout from the University of Edinburgh. SeaWarm is pioneering the development of innovative, modular water-source heat pumps… Continue reading SeaWarm’s Isabel DiPirro, Head of Operations & Sustainability, on market demand, commercialisation and national expansion
EnteroBiotix has completed enrolment in a Phase 2a clinical trial
EnteroBiotix has completed enrolment in a Phase 2a clinical trial (called MAST). The trial is testing EBX-102-02, a microbiome-based therapy. It includes 50 adult patients undergoing allogeneic haematopoietic stem cell transplantation (allo-HSCT). Patients receive either EBX-102-02 or a placebo before chemotherapy and transplant; They are followed for 12 months after transplant. The goal is to… Continue reading EnteroBiotix has completed enrolment in a Phase 2a clinical trial
Scottish biotech Lentitek Ltd has raised a total of £1 million in funding
Scottish biotech Lentitek Ltd has raised a total of £1 million in funding to advance its next-generation cancer technology, combining £700,000 in private investment led by Equity Gap with a £300,000 grant from Innovate UK. The Edinburgh-based company is developing manufacturing technologies for lentiviral vectors, a critical component in CAR-T cell and gene therapies used… Continue reading Scottish biotech Lentitek Ltd has raised a total of £1 million in funding
Sunamp wins Institute of Physics (IOP) Business Innovation Award
Sunamp has been awarded the Institute of Physics (IOP) Business Innovation Award, recognising a breakthrough in compact thermal storage that significantly improves heat transfer performance in high flow-rate hot water applications. The award highlights Sunamp’s development of advanced finned-tube heat exchanger technology, delivering major gains in heat transfer efficiency and energy storage performance for hot… Continue reading Sunamp wins Institute of Physics (IOP) Business Innovation Award